| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 79.15B | 63.75B | 51.61B | 42.01B | 39.15B |
| Gross Profit | 17.17B | 13.66B | 11.26B | 8.89B | 8.21B |
| EBITDA | 9.48B | 8.49B | 7.21B | 4.70B | 4.26B |
| Net Income | 6.31B | 4.17B | 3.38B | 2.19B | 1.93B |
Balance Sheet | |||||
| Total Assets | 124.70B | 99.82B | 82.76B | 72.36B | 65.04B |
| Cash, Cash Equivalents and Short-Term Investments | 15.36B | 11.74B | 13.71B | 12.86B | 11.84B |
| Total Debt | 14.71B | 10.38B | 10.04B | 9.99B | 9.72B |
| Total Liabilities | 81.03B | 64.01B | 50.40B | 42.49B | 41.79B |
| Stockholders Equity | 43.34B | 35.50B | 32.03B | 29.49B | 22.98B |
Cash Flow | |||||
| Free Cash Flow | 5.63B | 1.89B | 2.92B | 2.34B | 3.19B |
| Operating Cash Flow | 11.38B | 6.73B | 6.46B | 4.65B | 5.71B |
| Investing Cash Flow | -11.64B | -4.18B | -5.92B | -2.44B | -4.70B |
| Financing Cash Flow | 647.00M | -1.93B | -1.23B | -1.18B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $102.81B | 24.91 | 26.17% | 1.55% | -0.14% | 72.35% | |
75 Outperform | $68.09B | 42.76 | 8.20% | 1.61% | 2.83% | 47.00% | |
74 Outperform | $96.54B | 23.10 | 17.66% | 1.73% | 11.86% | 17.39% | |
74 Outperform | $151.41B | 30.63 | 76.87% | 2.77% | 2.88% | -35.15% | |
71 Outperform | $38.70B | 60.36 | 13.59% | 0.27% | 27.43% | 35.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $43.61B | 355.65 | 4.48% | ― | 31.77% | -15.34% |